Latest & greatest articles for atrial fibrillation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on atrial fibrillation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on atrial fibrillation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for atrial fibrillation

1. Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery

Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation (...) . Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery , , , , , , , , Collaborators, Affiliations Expand Collaborators ART Investigators

2020 EvidenceUpdates

2. KardiaMobile for the ambulatory detection of atrial fibrillation

KardiaMobile for the ambulatory detection of atrial fibrillation KardiaMobile for the ambulatory detection of atrial fibrillation Medtech innovation briefing Published: 29 October 2020 www.nice.org.uk/guidance/mib232 pathways This advice replaces MIB35. Summary Summary • The technology technology described in this briefing is the KardiaMobile heart monitor and Kardia app (AliveCor) used for identifying atrial fibrillation (AF). • The innovative aspect innovative aspect is its simple mode (...) it to a healthcare professional for interpretation. KardiaMobile has 2 electrodes on the top surface; 2 fingers from the left hand are placed onto 1 electrode and 2 fingers from the right hand are placed onto the other electrode. The user must keep their arms still and must keep touching the electrodes for at least 30 seconds for a complete reading to be taken. The company recommends that recordings are taken daily, or whenever atrial fibrillation (AF) symptoms are experienced. A user may also be given specific

2020 National Institute for Health and Clinical Excellence - Advice

3. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. (Abstract)

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. Despite improvements in the management of atrial fibrillation, patients with this condition remain at increased risk for cardiovascular complications. It is unclear whether early rhythm-control therapy can reduce this risk.In this international, investigator-initiated, parallel-group, open, blinded-outcome-assessment trial, we randomly assigned patients who had early atrial fibrillation (diagnosed ≤1 year before enrollment (...) ) and cardiovascular conditions to receive either early rhythm control or usual care. Early rhythm control included treatment with antiarrhythmic drugs or atrial fibrillation ablation after randomization. Usual care limited rhythm control to the management of atrial fibrillation-related symptoms. The first primary outcome was a composite of death from cardiovascular causes, stroke, or hospitalization with worsening of heart failure or acute coronary syndrome; the second primary outcome was the number of nights

2020 NEJM

4. Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial. Full Text available with Trip Pro

Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial. To investigate whether opportunistic screening in primary care increases the detection of atrial fibrillation compared with usual care.Cluster randomised controlled trial.47 intention-to-screen and 49 usual care primary care practices in the Netherlands, not blinded for allocation; the study was carried out from September 2015 to August 2018.In each practice (...) , a fixed sample of 200 eligible patients, aged 65 or older, with no known history of atrial fibrillation in the electronic medical record system, were randomly selected. In the intention-to-screen group, 9218 patients eligible for screening were included, 55.0% women, mean age 75.2 years. In the usual care group, 9526 patients were eligible for screening, 54.3% women, mean age 75.0 years.Opportunistic screening (that is, screening in patients visiting their general practice) consisted of three index

2020 BMJ

5. Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial Full Text available with Trip Pro

Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features (...) navigation Eur Heart J Actions . 2020 Aug 29;ehaa617. doi: 10.1093/eurheartj/ehaa617. Online ahead of print. Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial , , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Cardiology & Critical Care Jessaziekenhuis Hasselt, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium. 2 Department

2020 EvidenceUpdates

6. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial Full Text available with Trip Pro

Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID (...) . Online ahead of print. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Collaborators, Affiliations Expand Collaborators CASA-AF Investigators : , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations 1 Royal Brompton & Harefield NHS Foundation Trust, Sydney Street, London SW3 6NP

2020 EvidenceUpdates

7. Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis

Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID (...) .2020.07.010. Online ahead of print. Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Cardiology and University Hospital Vall d'hebron, Universitat Autònoma, Barcelona, Spain; Research Institute, University Hospital Vall d'hebron, CIBERCV, Barcelona, Spain. Electronic address: asambola@vhebron.net. 2 Department of Cardiology

2020 EvidenceUpdates

8. Comparison of catheter and surgical ablation of atrial fibrillation: A systemic review and meta-analysis of randomized trials

Comparison of catheter and surgical ablation of atrial fibrillation: A systemic review and meta-analysis of randomized trials Comparison of catheter and surgical ablation of atrial fibrillation: A systemic review and meta-analysis of randomized trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly (...) ahead of print. Comparison of catheter and surgical ablation of atrial fibrillation: A systemic review and meta-analysis of randomized trials , , , , Affiliations Expand Affiliations 1 Department of Cardiovascular Surgery, the First Affiliated Hospital, Nanjing Medical University, Nanjing, China. 2 Department of Geriatric Intensive Care Unit, the First Affiliated Hospital, Nanjing Medical University, Nanjing, China. 3 State Key Laboratory of Reproductive Medicine, School of Public Health, Nanjing

2020 EvidenceUpdates

9. Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?

Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation? Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation? - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving (...) We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation? , , , , , Affiliations Expand Affiliations 1 Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Denmark; Department of Medicine, North Denmark Regional Hospital, Hjørring, Denmark. Electronic address: t.overvad@rn.dk. 2 Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Denmark

2020 EvidenceUpdates

10. The Association between Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation

The Association between Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation The Association between Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving (...) Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation , , , , Affiliations Expand Affiliations 1 Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada. 2 Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada. 3 Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada. 4 Département de Médecine Générale, Université de Nantes, Nantes

2020 EvidenceUpdates

11. Association of New-Onset Atrial Fibrillation After Noncardiac Surgery With Subsequent Stroke and Transient Ischemic Attack. (Abstract)

Association of New-Onset Atrial Fibrillation After Noncardiac Surgery With Subsequent Stroke and Transient Ischemic Attack. Outcomes of postoperative atrial fibrillation (AF) after noncardiac surgery are not well defined.To determine the association of new-onset postoperative AF vs no AF after noncardiac surgery with risk of nonfatal and fatal outcomes.Retrospective cohort study in Olmsted County, Minnesota, involving 550 patients who had their first-ever documented AF within 30 days after

2020 JAMA

12. Be still my quivering heart: alcohol and atrial fibrillation

Be still my quivering heart: alcohol and atrial fibrillation August 10, 2020 Be still my quivering heart: alcohol and atrial fibrillation Clinical Question: Does advising patients to abstain from alcohol prevent atrial fibrillation recurrence? Bottom Line: Observational studies consistently report a dose- response association between alcohol and new onset atrial fibrillation. Based on 1 randomized controlled trial (RCT) of “regular drinkers” with paroxysmal atrial fibrillation, recurrence (...) of atrial fibrillation happened in ~50% who abstain compared to ~70% who continue drinking. Abstaining can prevent 1 atrial fibrillation-related hospital visit for every 9 people compared to those who continue to drink at 6 months. Evidence: • Open-label RCT in Australia, 140 patients with atrial fibrillation for ~6 years (mainly paroxysmal) and “regular” alcohol use (mean 16 per week). Mean age 62, 85% male, randomized to oral and written advice to abstain from alcohol with monthly follow-up

2020 Tools for Practice

13. 2020 Atrial Fibrillation (Management of) Guidelines

2020 Atrial Fibrillation (Management of) Guidelines 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Navbar Search Filter Mobile Microsite Search Term (...) search filter search input Article Navigation Close mobile search navigation Article Navigation Article Contents Article Navigation 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA

2020 European Society of Cardiology

14. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke

Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke Diagnostics guidance Published: 2 September 2020 www.nice.org.uk/guidance/dg41 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration (...) atrial fibrillation after cryptogenic stroke (DG41) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 50Contents Contents 1 Recommendations 4 2 The diagnostic tests 6 Clinical need and practice 6 The interventions 6 The comparator 11 3 Evidence 12 Clinical effectiveness 12 Cost effectiveness 26 4 Committee discussion 35 Clinical need 35 Clinical effectiveness 36 Cost effectiveness 38 Research considerations 45 5

2020 National Institute for Health and Clinical Excellence - Diagnostics Guidance

15. Quality Indicators for the Care and Outcomes of Adults with Atrial Fibrillation: Task Force for the Development of Quality Indicators in Atrial Fibrillation of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)

Quality Indicators for the Care and Outcomes of Adults with Atrial Fibrillation: Task Force for the Development of Quality Indicators in Atrial Fibrillation of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) Quality indicators for the care and outcomes of adults with atrial fibrillation Task Force for the development of quality indicators in atrial fibrillation of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC (...) , as well as PROMs. Conclusion This document de?nes six domains of AF care (patient assessment, anticoagulation, rate control, rhythm control, risk factor management, and outcomes), and provides 17 main and 17 secondary QIs for the diagnosis and manage- ment of AF. It is anticipated that implementation of these QIs will improve the quality of AF care. Keywords Atrial ?brillation • Quality indicators • Outcome measures Abbreviations AF atrial fibrillation EORP EURObservational

2020 Heart Rhythm Society

16. Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. (Abstract)

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. Implementation of appropriate oral anticoagulant treatment for the prevention of stroke in very elderly patients with atrial fibrillation is challenging because of concerns regarding bleeding.We conducted a phase 3, multicenter, randomized, double-blind, placebo-controlled, event-driven trial to compare a once-daily 15-mg dose of edoxaban with placebo in elderly Japanese patients (≥80 years of age) with nonvalvular atrial (...) , 1.87; 95% CI, 0.90 to 3.89; P = 0.09). There were substantially more events of gastrointestinal bleeding in the edoxaban group than in the placebo group. There was no substantial between-group difference in death from any cause (9.9% in the edoxaban group and 10.2% in the placebo group; hazard ratio, 0.97; 95% CI, 0.69 to 1.36).In very elderly Japanese patients with nonvalvular atrial fibrillation who were not appropriate candidates for standard doses of oral anticoagulants, a once-daily 15-mg dose

2020 NEJM

17. Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study. Full Text available with Trip Pro

Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study. To assess temporal trends in the association between newly diagnosed atrial fibrillation and death.Community based cohort study.Framingham Heart Study cohort, in 1972-85, 1986-2000, and 2001-15 (periods 1-3, respectively), in Framingham, MA, USA.Participants with no atrial fibrillation, aged 45-95 in each time period, and identified with newly diagnosed atrial (...) fibrillation (or atrial flutter) during each time period.The main outcome was all cause mortality. Hazard ratios for the association between time varying atrial fibrillation and all cause mortality were calculated with adjustment for time varying confounding factors. The difference in restricted mean survival times, adjusted for confounders, between participants with atrial fibrillation and matched referents at 10 years after a diagnosis of atrial fibrillation was estimated. Meta-regression was used

2020 BMJ

18. Baseline CHADS2 Score and Risk of Cardiovascular Events in the Population Without Atrial Fibrillation

Baseline CHADS2 Score and Risk of Cardiovascular Events in the Population Without Atrial Fibrillation Baseline CHADS2 Score and Risk of Cardiovascular Events in the Population Without Atrial Fibrillation - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health (...) new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Am J Cardiol Actions . 2020 Aug 15;129:30-35. doi: 10.1016/j.amjcard.2020.05.035. Epub 2020 Jun 3. Baseline CHADS2 Score and Risk of Cardiovascular Events in the Population Without Atrial Fibrillation , , , , , , Affiliations Expand

2020 EvidenceUpdates

19. Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review

Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Stroke Actions . 2020 Jul;51(7):2244-2248. doi: 10.1161/STROKEAHA.120.029340. Epub 2020 Jun 5. Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke

2020 EvidenceUpdates

20. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation

Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get (...) there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation J Am Coll Cardiol Actions . 2020 Jun 30;75(25):3122-3135. doi: 10.1016/j.jacc.2020.04.067. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation

2020 EvidenceUpdates